Eiffel names CEO as executive director
Monday, 02 June, 2003
Eiffel Technologies' CEO Christine Cussen has joined the company's board as an executive director.
Formerly managing director of AstraZeneca Pharmaceuticals, Cussen joined Melbourne-based Eiffel in October 2000 to oversee the development and commercialisation of the company's supercritical fluid technologies.
"She has brought strong professional marketing and management expertise to Eiffel at a time when we were seeking to increase the exposure of our technologies to our customer base and international pharmaceutical companies worldwide. She is a very valued employee and we recognise that she will make a significant contribution at Board level to the success of the company," said chairman Tom Hartigan.
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
